BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1350 related articles for article (PubMed ID: 18463380)

  • 41. Targeting VEGF/VEGFR in the treatment of psoriasis.
    Li W; Man XY; Chen JQ; Zhou J; Cai SQ; Zheng M
    Discov Med; 2014 Sep; 18(98):97-104. PubMed ID: 25227750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The angiogenic status of B-CLL B cells: role of the VEGF receptors.
    Kay NE
    Leuk Res; 2004 Mar; 28(3):221-2. PubMed ID: 14687614
    [No Abstract]   [Full Text] [Related]  

  • 43. Vascular endothelial growth factor and its receptors in multiple myeloma.
    Ria R; Roccaro AM; Merchionne F; Vacca A; Dammacco F; Ribatti D
    Leukemia; 2003 Oct; 17(10):1961-6. PubMed ID: 14513045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The vascular endothelial growth factor family and its receptors.
    Parikh AA; Ellis LM
    Hematol Oncol Clin North Am; 2004 Oct; 18(5):951-71, vii. PubMed ID: 15474329
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angiogenesis: novel and basic science insights and human therapy - keystone symposium.
    Iruela-Arispe L
    IDrugs; 2004 Feb; 7(2):111-3. PubMed ID: 15057650
    [No Abstract]   [Full Text] [Related]  

  • 46. Anticancer therapy with angiogenesis inhibitors.
    Ghilardi C; Bani MR; Giavazzi R
    Tumori; 2001; 87(6):S14-6. PubMed ID: 11989610
    [No Abstract]   [Full Text] [Related]  

  • 47. Regulators of angiogenesis as targets for anti-angiogenic tumor therapy.
    Breier G; Heidenreich R; Gaumann A; Groot M; Licht A; Nicolaus A; Schmitz J; Reichmann E; Plate KH; Vajkoczy P
    Ann Hematol; 2002; 81 Suppl 2():S71-2. PubMed ID: 12611084
    [No Abstract]   [Full Text] [Related]  

  • 48. Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis.
    Shibuya M
    BMB Rep; 2008 Apr; 41(4):278-86. PubMed ID: 18452647
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angiogenesis inhibition in cancer therapy: platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: biological functions and role in malignancy.
    Appelmann I; Liersch R; Kessler T; Mesters RM; Berdel WE
    Recent Results Cancer Res; 2010; 180():51-81. PubMed ID: 20033378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. III. Angiogenesis: complexity of tumor vasculature and microenvironment.
    Furuya M; Yonemitsu Y; Aoki I
    Curr Pharm Des; 2009; 15(16):1854-67. PubMed ID: 19519428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Advances of VEGF related molecular promoting tumor angiogenesis and targeting therapy].
    Guo ZY; Cao BL
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):282-4. PubMed ID: 20654135
    [No Abstract]   [Full Text] [Related]  

  • 52. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.
    Takahashi H; Shibuya M
    Clin Sci (Lond); 2005 Sep; 109(3):227-41. PubMed ID: 16104843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of the vascular endothelial growth factor-Delta-like 4 ligand/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions.
    Hainaud P; Contrerès JO; Villemain A; Liu LX; Plouët J; Tobelem G; Dupuy E
    Cancer Res; 2006 Sep; 66(17):8501-10. PubMed ID: 16951162
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-angiogenesis: biology is the foundation for therapy.
    Gerber HP
    Drug Discov Today; 2003 Apr; 8(8):344-6. PubMed ID: 12681937
    [No Abstract]   [Full Text] [Related]  

  • 55. The multifaceted activity of VEGF in angiogenesis - Implications for therapy responses.
    Moens S; Goveia J; Stapor PC; Cantelmo AR; Carmeliet P
    Cytokine Growth Factor Rev; 2014 Aug; 25(4):473-82. PubMed ID: 25169850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumoral angiogenesis: review of the literature.
    Khosravi Shahi P; Fernández Pineda I
    Cancer Invest; 2008 Feb; 26(1):104-8. PubMed ID: 18181052
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Inhibition of the VEGF receptor system with tyrosine kinase inhibitors. Angiogenesis inhibition in oncology].
    Mross K
    Pharm Unserer Zeit; 2008; 37(5):404-15. PubMed ID: 18729270
    [No Abstract]   [Full Text] [Related]  

  • 58. [Basic science of angiogenesis and its progress in clinical application].
    Takakura N
    Rinsho Ketsueki; 2008 Oct; 49(10):1451-9. PubMed ID: 18833929
    [No Abstract]   [Full Text] [Related]  

  • 59. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis.
    Presta M; Dell'Era P; Mitola S; Moroni E; Ronca R; Rusnati M
    Cytokine Growth Factor Rev; 2005 Apr; 16(2):159-78. PubMed ID: 15863032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Angiogenesis as part of the tumor "ecosystem" and possibilities to influence it].
    Klener P
    Klin Onkol; 2010; 23(1):14-20. PubMed ID: 20192069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 68.